Dimerix starts COVID-19 drug trials

By Jessica Mascione

15/10/2021 - 14:00

Health COVID-19

Perth-founded biopharmaceutical business Dimerix has launched phase three drug trials for patients with COVID-19 and kidney diseases.

To read our articles you will need to either login or subscribe.

Your single user subscription provides more than you think